CTI BIOPHARMA CORP Modification Agreements

12 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Amendment to Loan and Security Agreement between Silicon Valley Bank and CTI BioPharma Corp.
Modification Agreements
CTI BIOPHARMA CORP
Biotechnology
2018
Side Letter #2 Amending Development, Commercialization and License Agreement between CTI BioPharma Corp. and Baxalta US Inc.
Modification Agreements
CTI BIOPHARMA CORP
Biotechnology
2016
Side Letter Amendment to Development, Commercialization and License Agreement between CTI BioPharma Corp. and Baxalta US Inc.
Modification Agreements
CTI BIOPHARMA CORP
Biotechnology
2016
Amendment to Equity/Long-Term Incentive Award Agreement between CTI BioPharma Corp. and Employee (December 23, 2015)
Modification Agreements
CTI BIOPHARMA CORP
Biotechnology
2016
Amendment to Equity/Long-Term Incentive Award Agreement between Cell Therapeutics, Inc. and Award Recipient
Modification Agreements
CTI BIOPHARMA CORP
Biotechnology
2014
Amendment to Equity/Long-Term Incentive Award Agreement between Cell Therapeutics, Inc. and Award Recipient
Modification Agreements
CTI BIOPHARMA CORP
Biotechnology
2013
Amendment to Restricted Stock Agreement between Cell Therapeutics, Inc. and Dr. James A. Bianco
Modification Agreements
CTI BIOPHARMA CORP
Biotechnology
2011
Amendment to Equity/Long-Term Incentive Award Agreement between Cell Therapeutics, Inc. and Award Recipient
Modification Agreements
CTI BIOPHARMA CORP
Biotechnology
2011
Amendment to Securities Purchase Agreement between Cell Therapeutics, Inc. and Enable Growth Partners LP et al., dated September 23, 2008
Modification Agreements
CTI BIOPHARMA CORP
Biotechnology
2008
Amendment Agreement to Securities Purchase Agreement between Cell Therapeutics, Inc. and Investor (August 6, 2008)
Modification Agreements
CTI BIOPHARMA CORP
Biotechnology
2008
Second Amendment to Securities Purchase Agreement and Series B Unit Purchase Warrant between Cell Therapeutics, Inc. and BAM Opportunity Fund LP
Modification Agreements
CTI BIOPHARMA CORP
Biotechnology
2008
Amendment to Securities Purchase Agreement and Series B Unit Purchase Warrant between Cell Therapeutics, Inc. and BAM Opportunity Fund LP
Modification Agreements
CTI BIOPHARMA CORP
Biotechnology
2008